Anyone that thinks that an uplist to Naz at 3 buck
Post# of 30028
The Nasdaq can be brutal for small cap biotechs. Ever heared of Adam Feuerstein and Jim Crammer? Not to mention the ruthless hedge funds that love to short small, unproven bio's.
The uplist needs to postponed until mid 2015 when revenue is flowing, partnerships are inked and IND's are filed.
IMO>>>>>>>>>>>>>>>>> GO GERALD